Olmesartan 20 mg costs vary depending on factors such as the pharmacy, insurance coverage, and whether a prescription discount is used.
What influences the price of Olmesartan 20 mg?
The price of Olmesartan 20 mg can be affected by the specific manufacturer of the generic drug, as well as the retail price set by individual pharmacies [1]. Insurance plans also play a significant role, with co-pays differing based on the formulary and the patient's specific plan details [2]. Discount programs and coupons can also lead to lower out-of-pocket costs for consumers [1].
How much does Olmesartan 20 mg typically cost without insurance?
Without insurance, a 30-day supply of Olmesartan 20 mg can range from approximately $20 to over $100 [1]. For example, prices might be around $25 for 30 tablets of 20 mg, or potentially higher, nearing $50 or more for the same quantity, depending on the brand and retailer [1].
Are there ways to get Olmesartan 20 mg for less?
Patients can often find lower prices for Olmesartan 20 mg by comparing costs at different pharmacies or by using prescription discount cards and coupons available online [1]. Some pharmacies offer their own discount programs that can reduce the cost of generic medications [1].
When does the patent for Olmesartan expire?
The original patent for Olmesartan medoxomil, the active ingredient in Olmesartan, has expired [3]. This expiration allows for the production and sale of generic versions of the drug, which typically leads to a decrease in overall cost [3].
Where can I find Olmesartan 20 mg pricing information?
Information on Olmesartan 20 mg pricing can be found on pharmacy websites, through online prescription discount providers, and on drug pricing comparison platforms [1]. DrugPatentWatch.com also provides information on drug patents, which can indirectly influence drug pricing by indicating when generic competition is possible [3].
Sources:
1. https://www.goodrx.com/olmesartan
2. https://www.costplusdrugs.com/medications/olmesartan-medoxomil-20-mg-tablet/
3. https://drugpatentwatch.com/